News/Healthcare
AI on the trail: Google Lens can tell you if what you’re looking at is poison ivy
AI tools have transformed the way we interact with and identify potential dangers in the natural world, offering new solutions for age-old outdoor problems. Smartphone-based AI applications now provide hikers, gardeners, and outdoor enthusiasts with reliable ways to identify poison ivy before accidental contact leads to painful, itchy rashes. This technological advancement addresses the notorious difficulty of distinguishing poison ivy from harmless lookalikes, making outdoor adventures safer and more enjoyable for everyone. 1. Use Google Lens for instant identification Google Lens offers perhaps the most seamless method for identifying poison ivy in real-time through your smartphone's camera. The app compares...
read May 20, 2025Indian healthcare AI startup Qure.AI targets IPO within 2 years
India's AI healthcare startup Qure.AI is targeting profitability within a year and plans an IPO within two years as it expands globally. The company's strategy highlights the rapidly growing market for AI in healthcare diagnostics, which is projected to surge from $14.92 billion to $110 billion by 2030, driven by increasing adoption for early disease detection and clinical workflow optimization. The big picture: Qure.AI, founded in 2016 and backed by Fractal Analytics, Peak XV Partners, and Novo Holdings, has raised $125 million to date and was valued at $264 million as of November 2024. CEO Prashant Warier revealed plans to...
read May 20, 2025AI therapist helps user overcome personal struggles
AI chatbots are carving out a controversial role in mental health support, offering 24/7 availability and immediate responses while raising serious concerns about data privacy and therapeutic effectiveness. The emergence of AI companions that can simulate emotional support highlights both the potential and limitations of technology in addressing the growing global mental health crisis, especially as traditional services struggle with long waiting lists and accessibility challenges. The big picture: AI chatbots are increasingly being used as informal mental health support tools, with some users forming deep emotional connections while waiting for professional human therapy. Kelly, who was on an NHS...
read May 19, 2025AI-designed irritable bowel disease drug enters human trials for the first time
Absci's generative AI-created antibody for irritable bowel disease enters clinical trials, marking a significant milestone for AI drug development. This Phase I trial represents one of the first attempts to secure regulatory approval for a therapy designed entirely using artificial intelligence, highlighting the pharmaceutical industry's ongoing efforts to transform the traditionally lengthy and expensive drug development process through AI-powered innovation. The big picture: Absci has begun Phase I clinical trials for ABS-101, an antibody therapy for irritable bowel disease created from scratch using generative AI. The company has officially dosed the first patients in the trial, administering the drug to...
read May 19, 2025UK implements AI to analyze public opinion on regulation of Botox, fillers
The UK government is breaking new ground by using artificial intelligence to streamline public consultation analysis, potentially saving millions while maintaining high-quality results. A landmark trial utilizing an AI tool called "Consult" to analyze responses about cosmetic procedures like Botox and fillers has demonstrated that machines can effectively match human performance in processing public feedback, signaling a significant shift in how governments might handle citizen input in the digital age. The big picture: A Scottish government consultation on regulating non-surgical cosmetic procedures has become the UK's first to employ artificial intelligence for analyzing public responses, with officials reporting the AI...
read May 19, 2025Moderna injects AI across operations to boost vaccine development
Moderna's AI transformation represents a bold organizational shift in pharmaceutical development, as the COVID-19 vaccine maker integrates artificial intelligence across every facet of its business operations. The company's extensive partnership with OpenAI has enabled the deployment of thousands of customized AI models designed to automate work previously handled by humans, leading to unconventional structural changes including the merger of its HR and technology departments under unified leadership. The big picture: Moderna has deployed over 3,000 GPTs across the company in a comprehensive AI implementation strategy that's reshaping its organizational structure. The biotech company has taken the unusual step of merging...
read May 19, 2025AI medical advice improves, but adoption remains a challenge
OpenAI's latest research shows chatbots are improving at answering medical questions, but a critical gap remains between the artificial testing environment and real-world medical emergencies. The company's new HealthBench evaluation framework tests how well AI models can provide medical advice through text-based interactions, yet it doesn't address how humans might actually interpret or act on AI-generated medical guidance during emergencies. This distinction highlights a fundamental challenge in medical AI: technical performance in controlled settings doesn't necessarily translate to beneficial real-world outcomes. The big picture: OpenAI's HealthBench tests AI models on their ability to respond appropriately to medical questions, including emergency...
read May 19, 2025Symptom Checker? Check! Fitbit Labs unveils 3 AI features to simplify health data
Fitbit is introducing three AI-powered health features that transform how users interact with medical information and track their physical wellbeing. These experimental Fitbit Labs capabilities bring sophisticated health monitoring to consumer wearables, marking a significant step toward personalized digital health management. The new tools aim to bridge the gap between complex medical data and everyday health understanding, though they come with important limitations about their diagnostic capabilities. The big picture: Fitbit announced three Gemini-powered AI features exclusively for Fitbit Labs users that help interpret medical records, check symptoms, and identify unusual health trends. The company's parent Google is leveraging its...
read May 19, 2025AI-powered protein mapping may unlock new treatments for Alzheimer’s and cancer
MIT and Harvard researchers have developed a groundbreaking computational approach that can predict protein locations within any human cell with unprecedented precision. This innovation addresses a critical challenge in biology and medicine, where mislocalized proteins contribute to diseases like Alzheimer's and cancer. By combining protein language models with advanced computer vision, the technology predicts subcellular protein localization at the single-cell level—even for protein-cell combinations never previously tested—opening new pathways for disease diagnosis and drug discovery. The big picture: The new AI-driven technique efficiently explores the vast uncharted space of protein localization across human cells, going beyond the limitations of existing...
read May 15, 2025AI therapists raise questions of privacy, safety in mental health care
The evolution of AI in psychology has progressed from diagnostic applications to therapeutic uses, raising fundamental questions about the technology's role in mental healthcare. Psychologists have been exploring AI applications since 2017, with early successes in predicting conditions like bipolar disorder and future substance abuse behavior, but today's concerns focus on more complex issues of privacy, bias, and the irreplaceable human elements of therapeutic relationships. The big picture: AI's entry into psychology began with diagnosis and prediction but now confronts the more nuanced challenge of providing therapy, with experts warning about significant ethical concerns. Early AI applications showed promising results,...
read May 15, 2025Apple explores mind-controlled iPhones for greater access for the disabled
Apple's brain-computer interface technology represents a groundbreaking approach to accessibility, potentially transforming how people with severe physical limitations interact with digital devices. By integrating thought-controlled navigation with AI voice synthesis, Apple is pioneering technology that could allow people with conditions like ALS to not only operate devices hands-free but also communicate through synthetic versions of their own voices—effectively bridging the gap between intention and expression for those physically unable to interact with technology through conventional means. The big picture: Apple plans to support Switch Control for brain-computer interfaces, allowing people with conditions like ALS to control iPhones, iPads, and Vision...
read May 14, 2025Meta AI speeds up scientific research with new data set and model
Meta is pioneering scientific research through massive data release that could revolutionize chemistry, drug discovery, and artificial intelligence. The company's Open Molecules 2025 project represents an unprecedented computational leap, generating 100 million quantum mechanics simulations requiring 6 billion compute hours — significantly larger than any previous academic dataset. This landmark scientific contribution could dramatically accelerate the process of developing new medications, materials, and more advanced AI systems. The big picture: Meta has released an enormous chemistry dataset and a new AI model that dramatically accelerates scientific discovery while potentially advancing general AI capabilities. The Open Molecules 2025 dataset required 6...
read May 14, 2025Radiologists thrive despite predictions of their demise through AI replacement
The prediction that AI would replace radiologists has fallen short, as these specialists remain in high demand despite significant technological advancements. While Geoffrey Hinton, now a Nobel laureate in Physics, forecasted in 2016 that AI would outperform human radiologists within five years, the reality has proven more nuanced. Instead of replacement, AI has become an enhancement tool that improves efficiency and accuracy while keeping skilled human professionals at the center of medical imaging diagnostics. The big picture: Contrary to Nobel Prize winner Geoffrey Hinton's 2016 prediction that AI would replace radiologists within five years, these medical specialists remain in high...
read May 14, 2025Neural networks trained on quantum physics are changing molecular science
The fusion of decentralized AI and molecular simulations is creating a breakthrough approach to drug discovery that could dramatically accelerate the development of new treatments. By generating high-fidelity simulations at the atomic level, researchers can predict molecular interactions with unprecedented speed and accuracy, potentially compressing years of laboratory work into days of computational modeling—all at a fraction of the traditional cost. The big picture: Rowan Labs has released Egret-1, an open-source suite of neural network potentials that can simulate organic chemistry with atomic precision at speeds up to a million times faster than conventional supercomputers. The technology trains AI not...
read May 14, 2025Doctors in Hull’s Jean Bishop Centre use AI to spend more time with patients
AI is transforming doctor-patient interactions at a specialized care center in Hull by automating clinical documentation, allowing physicians to focus more on patient care rather than administrative tasks. This technological advancement represents a significant shift in healthcare delivery, potentially addressing critical issues like physician burnout while enhancing the quality of patient interactions through more engaged, face-to-face conversations. The big picture: GPs at Hull's Jean Bishop Centre are using AI to transcribe consultations and generate clinical documentation, cutting administrative work by at least half while improving patient engagement. The AI system creates consultation transcripts, converts conversations into medical record notes, and...
read May 14, 2025Health data gets a makeover with Fitbit’s Gemini upgrade
Fitbit is expanding its AI capabilities with a new suite of health tools powered by Google Gemini. These experimental features introduce users to AI-enhanced health insights, allowing them to better understand lab results, decode symptoms, and receive alerts about unusual health metric changes. The integration represents a significant advancement in consumer health tech, where AI is being leveraged to translate complex medical information into accessible formats while maintaining appropriate boundaries between AI assistance and professional medical care. The big picture: Fitbit Labs is introducing three new Google Gemini-powered experimental features that transform how users interact with their health data. The...
read May 13, 2025AI’s new role in identifying neuron types could transform neurological treatments
AI is achieving a breakthrough in neuroscience by accurately identifying brain cell types from electrical activity recordings, providing potential new avenues for treating neurological disorders. This innovation enables scientists to distinguish between neuron types with remarkable precision, overcoming limitations of current neurotechnology that can record brain activity but cannot differentiate between specific neuron classifications—a capability that could transform how researchers understand and treat conditions ranging from autism to Parkinson's disease. The breakthrough: Scientists have developed an AI deep learning algorithm that can distinguish between different brain cell types with over 95% accuracy based on their electrical activity patterns. A multinational...
read May 12, 2025The FDA is swallowing AI to speed up the drug approval process
The FDA is rapidly deploying artificial intelligence across its operations in an ambitious effort to transform drug review processes. This government-wide push toward AI integration showcases both the potential efficiency gains and inherent risks of implementing generative AI in highly regulated environments where scientific accuracy is paramount and errors could have significant public health implications. The big picture: The FDA has announced immediate implementation of AI tools across all centers following a generative AI pilot program for scientific reviewers, with full agency-wide integration mandated by June 30. The agency is promoting the technology as a way to accelerate drug reviews...
read May 12, 2025AI drug firm METiS eyes $200M Hong Kong IPO
AI-driven drug discovery firm METiS Pharmaceuticals is exploring a potential Hong Kong IPO that could raise up to $200 million, according to sources familiar with the matter. This move highlights the growing intersection of artificial intelligence and pharmaceutical development, with innovative companies seeking capital to advance their drug delivery and discovery capabilities. If completed before year-end as targeted, the offering would represent a significant milestone in the commercialization of AI-powered drug development platforms. The big picture: METiS Pharmaceuticals is working with advisers to prepare for a potential initial public offering on the Hong Kong stock exchange, targeting a raise of...
read May 12, 2025DiffSMol uses AI to design 3D drug molecules with better precision
AI-powered drug discovery has taken a significant leap forward with DiffSMol, a new generative AI method that creates 3D molecules specifically designed to bind with target proteins. This breakthrough approach, developed by researchers at multiple institutions, substantially outperforms existing methods by generating molecules that both match desired shapes and optimize binding affinities—potentially transforming the traditionally slow, resource-intensive process of developing new pharmaceutical compounds. The big picture: Researchers have developed DiffSMol, a generative AI method that designs 3D drug molecules based on known ligand shapes, dramatically outperforming existing approaches in both shape similarity and binding affinity. The system leverages pretrained shape...
read May 12, 2025Researchers use FaceAge to link facial aging with cancer outcomes
Artificial intelligence is revolutionizing healthcare diagnostics by turning our faces into valuable medical data points. A groundbreaking deep learning model called FaceAge can now predict mortality risk in cancer patients by analyzing facial features that reveal biological aging—potentially transforming how doctors evaluate patient health. This technology represents a significant advancement in AI-powered predictive medicine, where a simple photograph might soon supplement traditional vital signs to provide critical insights about underlying health conditions and life expectancy. The big picture: FaceAge uses deep learning to estimate biological age from facial photographs with remarkable accuracy, detecting subtle markers of aging that correlate with...
read May 12, 2025AI therapy chatbots raise safety concerns among UK experts
Mental health professionals are raising significant concerns about AI therapy chatbots amid their growing popularity, highlighting a fundamental tension between tech companies' ambitious vision and clinical reality. As Mark Zuckerberg promotes the idea that "everyone should have a therapist" and suggests AI could fill this role, UK experts are emphasizing critical limitations in AI's capacity to provide nuanced, safe mental health support. This debate underscores broader questions about AI's appropriate boundaries in sensitive areas like psychological care, where inappropriate advice could cause real harm. The big picture: Mental health clinicians warn that AI chatbots lack the nuance and clinical judgment...
read May 8, 2025AI-inflected White House budget cuts make pharmaceutical researchers queasy
The growing crisis in clinical trials is intensifying as pharmaceutical companies face skyrocketing costs, diminishing success rates, and operational challenges. While many stakeholders are turning to artificial intelligence as a potential solution, proposed federal budget cuts threaten to undermine the research ecosystem at its foundation. This situation highlights a critical tension between technological innovation and sustainable research funding that could reshape America's position as a global leader in medical and pharmaceutical research. The big picture: Clinical trials are experiencing a perfect storm of challenges at the same time the White House has proposed slashing NIH funding by nearly $18 billion,...
read May 8, 2025AI could speed up FDA drug evaluation process
The FDA is exploring a partnership with OpenAI to accelerate the drug approval process through artificial intelligence, potentially transforming how new medications reach patients. This initiative represents a significant shift in regulatory technology application, as the FDA commissioner recently revealed the agency has already completed its first AI-assisted scientific review and is actively pursuing further AI integration to address the decade-long timeline typically required for new drugs to reach the market. The big picture: FDA commissioner Marty Makary has publicly questioned the lengthy drug approval process and signaled the agency's commitment to modernization through artificial intelligence. Makary wrote on social...
read